Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Carter-Edwards, L, Jackson, SA, Runaldue, MJ, and Svetkey, LP. "Diet- and blood pressure-related knowledge, attitudes, and hypertension prevalence among African Americans: the KDBP Study. Knowledge of Diet and Blood Pressure." Ethnicity & Disease 12, no. 1 (January 2002): S1-72-82-null.

PMID
11913625
Scholars@Duke

Vollmer, WM, Sacks, FM, Ard, J, Appel, LJ, Bray, GA, Simons-Morton, DG, Conlin, PR, Svetkey, LP, Erlinger, TP, Moore, TJ, Karanja, N, and DASH-Sodium Trial Collaborative Research Group, . "Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial." Annals of Internal Medicine 135, no. 12 (December 2001): 1019-1028.

PMID
11747380
Full Text

Svetkey, LP, Moore, TJ, Simons-Morton, DG, Appel, LJ, Bray, GA, Sacks, FM, Ard, JD, Mortensen, RM, Mitchell, SR, Conlin, PR, Kesari, M, and DASH collaborative research group, . "Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study." Journal of Hypertension 19, no. 11 (November 2001): 1949-1956.

PMID
11677359
Full Text

Obarzanek, E, Proschan, MA, Moore, TJ, Sacks, FM, Svetkey, LP, Appel, LJ, Vollmer, WM, Most-Windhauser, MM, and Cutler, JA. "Variability in blood pressure response to salt intake." Circulation 104, no. 17 (October 23, 2001): 811-812.

Scholars@Duke

Moore, TJ, Conlin, PR, Ard, J, and Svetkey, LP. "DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension." Hypertension (Dallas, Tex. : 1979) 38, no. 2 (August 2001): 155-158.

PMID
11509468
Full Text

Sacks, FM, Porschan, MA, and Svetkey, LP. "Dietary sodium and blood pressure. Reply." New England Journal of Medicine 344, no. 22 (May 31, 2001): 1718-1719. (Letter)

Scholars@Duke

Alderman, M. "Dietary sodium and blood pressure." The New England Journal of Medicine 344, no. 22 (May 2001): 1716-null. (Letter)

PMID
11386274
Full Text

Vollmer, WM, Sacks, FM, and Svetkey, LP. "New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products." Current Controlled Trials in Cardiovascular Medicine 2, no. 2 (January 2001): 71-74.

PMID
11806776
Full Text

Sacks, FM, Svetkey, LP, Vollmer, WM, Appel, LJ, Bray, GA, Harsha, D, Obarzanek, E, Conlin, PR, Miller, ER, Simons-Morton, DG, Karanja, N, Lin, PH, and DASH-Sodium Collaborative Research Group, . "Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group." The New England Journal of Medicine 344, no. 1 (January 2001): 3-10.

PMID
11136953
Full Text

Appel, LJ, Conlin, PR, Harsha, DW, Meltesen, GT, Mitchell, SR, Moore, TJ, Sacks, FM, and Svetkey, LP. "A clinical trial of the effects of sodium reduction and the DASH diet on ambulatory blood pressure: Results from the DASH-sodium feeding study." Circulation 102, no. 18 (October 31, 2000): 416-416.

Scholars@Duke

Pages